Using a model of reversible EMT based on a TNFα/TGFβ treatment of the lung cancer cell line A549, they showed an up-regulation of PD–L1, with a demethylation of its promoter via the NFκB pathway [30]. This evidence concerns the gene TGFB1 and lung carcinoma.